632 related articles for article (PubMed ID: 31351880)
1. AGA Technical Review on the Evaluation of Functional Diarrhea and Diarrhea-Predominant Irritable Bowel Syndrome in Adults (IBS-D).
Carrasco-Labra A; Lytvyn L; Falck-Ytter Y; Surawicz CM; Chey WD
Gastroenterology; 2019 Sep; 157(3):859-880. PubMed ID: 31351880
[TBL] [Abstract][Full Text] [Related]
2. AGA Clinical Practice Guidelines on the Laboratory Evaluation of Functional Diarrhea and Diarrhea-Predominant Irritable Bowel Syndrome in Adults (IBS-D).
Smalley W; Falck-Ytter C; Carrasco-Labra A; Wani S; Lytvyn L; Falck-Ytter Y
Gastroenterology; 2019 Sep; 157(3):851-854. PubMed ID: 31302098
[No Abstract] [Full Text] [Related]
3. AGA Clinical Practice Guidelines on the Laboratory Evaluation of Functional Diarrhea and Diarrhea-Predominant Irritable Bowel Syndrome in Adults (IBS-D): Patient Summary.
American Gastroenterological Association
Gastroenterology; 2019 Sep; 157(3):856-857. PubMed ID: 31378676
[No Abstract] [Full Text] [Related]
4. Spotlight: Laboratory Evaluation of Functional Diarrhea and Diarrhea-Predominant Irritable Bowel Syndrome in Adults (IBS-D).
Smalley W; Falck-Ytter C; Carrasco-Labra A; Wani S; Lytvyn L; Falck-Ytter Y
Gastroenterology; 2019 Sep; 157(3):858. PubMed ID: 31377275
[No Abstract] [Full Text] [Related]
5. Irritable Bowel Syndrome in Adults (IBS-D): Clinical Decision Support Tool.
American Gastroenterological Association
Gastroenterology; 2019 Sep; 157(3):855. PubMed ID: 31323183
[No Abstract] [Full Text] [Related]
6. ACG Clinical Guideline: Management of Irritable Bowel Syndrome.
Lacy BE; Pimentel M; Brenner DM; Chey WD; Keefer LA; Long MD; Moshiree B
Am J Gastroenterol; 2021 Jan; 116(1):17-44. PubMed ID: 33315591
[TBL] [Abstract][Full Text] [Related]
7. Assessment of Anti-vinculin and Anti-cytolethal Distending Toxin B Antibodies in Subtypes of Irritable Bowel Syndrome.
Rezaie A; Park SC; Morales W; Marsh E; Lembo A; Kim JH; Weitsman S; Chua KS; Barlow GM; Pimentel M
Dig Dis Sci; 2017 Jun; 62(6):1480-1485. PubMed ID: 28451914
[TBL] [Abstract][Full Text] [Related]
8. A meta-analysis of the utility of C-reactive protein, erythrocyte sedimentation rate, fecal calprotectin, and fecal lactoferrin to exclude inflammatory bowel disease in adults with IBS.
Menees SB; Powell C; Kurlander J; Goel A; Chey WD
Am J Gastroenterol; 2015 Mar; 110(3):444-54. PubMed ID: 25732419
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of chronic diarrhea and irritable bowel syndrome with diarrhea in adults in the era of precision medicine.
Schiller LR
Am J Gastroenterol; 2018 May; 113(5):660-669. PubMed ID: 29713027
[TBL] [Abstract][Full Text] [Related]
10. Biomarkers for bile acid diarrhoea in functional bowel disorder with diarrhoea: a systematic review and meta-analysis.
Valentin N; Camilleri M; Altayar O; Vijayvargiya P; Acosta A; Nelson AD; Murad MH
Gut; 2016 Dec; 65(12):1951-1959. PubMed ID: 26347530
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of a biomarker for diarrhea-predominant irritable bowel syndrome in human subjects.
Pimentel M; Morales W; Rezaie A; Marsh E; Lembo A; Mirocha J; Leffler DA; Marsh Z; Weitsman S; Chua KS; Barlow GM; Bortey E; Forbes W; Yu A; Chang C
PLoS One; 2015; 10(5):e0126438. PubMed ID: 25970536
[TBL] [Abstract][Full Text] [Related]
12. Excluding inflammatory bowel disease in the irritable bowel syndrome patient: how far to go?
Nemakayala DR; Cash BD
Curr Opin Gastroenterol; 2019 Jan; 35(1):58-62. PubMed ID: 30407259
[TBL] [Abstract][Full Text] [Related]
13. Patients with irritable bowel syndrome-diarrhea have lower disease-specific quality of life than irritable bowel syndrome-constipation.
Singh P; Staller K; Barshop K; Dai E; Newman J; Yoon S; Castel S; Kuo B
World J Gastroenterol; 2015 Jul; 21(26):8103-9. PubMed ID: 26185382
[TBL] [Abstract][Full Text] [Related]
14. Irritable bowel syndrome: a clinical review.
Chey WD; Kurlander J; Eswaran S
JAMA; 2015 Mar; 313(9):949-58. PubMed ID: 25734736
[TBL] [Abstract][Full Text] [Related]
15. Accuracy of four fecal assays in the diagnosis of colitis.
Schoepfer AM; Trummler M; Seeholzer P; Criblez DH; Seibold F
Dis Colon Rectum; 2007 Oct; 50(10):1697-706. PubMed ID: 17762964
[TBL] [Abstract][Full Text] [Related]
16. Serum 7-alfa-hydroxy-4-cholesten-3-one and fibroblast growth factor-19 as biomarkers diagnosing bile acid malabsorption in microscopic colitis and inflammatory bowel disease.
Lyutakov I; Lozanov V; Sugareva P; Valkov H; Penchev P
Eur J Gastroenterol Hepatol; 2021 Mar; 33(3):380-387. PubMed ID: 33177381
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic accuracy of faecal calprotectin estimation in prediction of abnormal small bowel radiology.
Dolwani S; Metzner M; Wassell JJ; Yong A; Hawthorne AB
Aliment Pharmacol Ther; 2004 Sep; 20(6):615-21. PubMed ID: 15352909
[TBL] [Abstract][Full Text] [Related]
18. Yield of diagnostic tests for celiac disease in individuals with symptoms suggestive of irritable bowel syndrome: systematic review and meta-analysis.
Ford AC; Chey WD; Talley NJ; Malhotra A; Spiegel BM; Moayyedi P
Arch Intern Med; 2009 Apr; 169(7):651-8. PubMed ID: 19364994
[TBL] [Abstract][Full Text] [Related]
19. [Fecal calprotectin in differential diagnosis of irritable bowel syndrome].
Li XG; Lu YM; Gu F; Yang XL
Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Jun; 38(3):310-3. PubMed ID: 16778979
[TBL] [Abstract][Full Text] [Related]
20. A Predictive Model to Estimate Cost Savings of a Novel Diagnostic Blood Panel for Diagnosis of Diarrhea-predominant Irritable Bowel Syndrome.
Pimentel M; Purdy C; Magar R; Rezaie A
Clin Ther; 2016 Jul; 38(7):1638-1652.e9. PubMed ID: 27261204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
